Table 2.
14 Months | 24 Months | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
VIP (n=110) |
BB (n=105) |
C (n=109) |
ESb BB vs. C |
ESb VIP vs. C |
VIP (n=161) |
BB (n=62) |
C (n=151) |
ESb BB vs. C |
ESb VIP vs. C |
|
READ | 8.03 2.68) |
7.32 (2.71) |
7.16 (2.56) |
0.09 | .39** | 8.44 (2.68) |
8.12 (2.45) |
7.82 (2.71) |
0.15 | .27* |
PIDA | 3.32 (1.54) |
3.00 (1.31) |
2.67 (1.45) |
.27* | .49*** | 3.51 (1.36) |
3.39 (1.35) |
3.39 (1.32) |
0.06 | 0.11 |
PVR | 8.61 (3.26) |
7.84 (2.78) |
7.30 (3.07) |
.24t | .48*** | 8.77 (3.30) |
7.47 (2.71) |
7.81 (2.89) |
0.02 | .36** |
ALM | 4.27 (1.78) |
3.74 (1.68) |
3.80 (1.78) |
0.08 | .22t | 5.23 (1.69) |
5.37 (1.30) |
5.19 (1.57) |
0.18 | 0.06 |
StimQ Total |
24.20 (7.09) |
21.91 (6.35 |
20.95 (6.43) |
.22t | .54*** | 25.94 (7.28) |
24.33 (5.93) |
24.21 (6.45) |
0.11 | .30** |
p<.05,
p<.01,
p<.001,
≤.10
Analyses adjusted for child age, gender, and maternal literacy/education
Effect size based on Cohen’s d